Fewer pension schemes are targeting self-sufficiency as their long-term objective while bulk annuity pricing improves and the consolidation market opens up.
The coronavirus pandemic is unlikely to curb pension scheme enthusiasm for buy-ins and buyouts, says Hymans Robertson.
A significant increase in so-called ‘mega-transactions’ accounted for around two-thirds of the record-breaking bulk-annuity transfer volumes for 2019, Hymans Robertson analysis reveals.
Zurich has agreed to insure £800m of longevity risk for the pensioners of a FTSE 100-sponsored pension scheme.
Pensions and risk consultancy Hymans Robertson has appointed two equity partners and five partners from across the firm.
The pension insurance market could be set for another record-breaking next year as schemes are already "in the queue" for deals at the start of next year, says Hymans Robertson.
Jonathan Stapleton asks how the combination of improved scheme funding and better insurer pricing could drive a resurgence in the take-up of full insurance buyouts.
BA deal marks 'new chapter' for risk reduction market; £20bn-plus of transactions expected this year as megadeals continue
The Airways Pension Scheme's £4.4bn buy-in with Legal & General, announced this morning, is set to mark a 'fundamental shift' in market dynamics with deal volumes of £20bn-plus for 2018 now looking possible, consultants say.
Hymans Robertson has appointed Baljit Khatra as a risk transfer consultant as the firm prepares for the busiest year ever for the bulk annuity market.
Hymans Robertson has launched a tool to help schemes more easily assess their readiness to complete a buy-in and the benefits this could bring.
Defined benefit (DB) schemes will offload around £700bn of liabilities to insurers over the next 15 years, latest analysis by Hymans Robertson has suggested.
Demand for buy-ins is set to triple over the next decade as more defined benefit (DB) schemes look to offload their liabilities to insurers.
The cost of longevity risk for defined benefit (DB) schemes has increased by 50% in the past 12 years due to falling long-term interest rates.
Aegon has sold a £6bn UK annuity portfolio to Rothesay Life in a bid to focus on expanding its investment platform.
As medically underwritten deals reach record levels, PP looks at why this market is booming.
The £150m Institution of Engineering and Technology ("IET") Superannuation and Assurance Scheme has completed a £32m medically underwritten buy-in.
The impact of Solvency II on bulk annuity pricing will be limited, but schemes with generous options could see hefty increases, finds Jack Jones
The market for enhanced bulk annuities has almost hit £700m after a bumper fourth quarter in which 10% of all transactions was medically underwritten, according to research from Hymans Robertson.
Pension fund trustees are increasingly responsible for managing risk, but lack the skills to do, according to research by a pension consultancy.
Natasha Browne explores the issues trustees face
Buy-in prices have fallen by up to 3% as a result of changes announced in last month's Budget, one consultant says.
The GeoPost UK Pension Scheme has secured a £30m buy-in with Pension Insurance Corporation (PIC) to cover liabilities relating to 645 pensioner members.
The Institute of Chartered Accountants Staff Pensions Fund has secured a medically underwritten buy-in to cover its highest value pensioner members.
Three funds including a Singaporean sovereign wealth fund have agreed to acquire a combined 64% stake in Rothesay Life from Goldman Sachs.